35Pharma

Montreal, Canada Founded: 2021 • Age: 5 yrs Acquired By GSK
Designs and develops innovative biologics for unmet medical needs in healthcare.

About 35Pharma

35Pharma is a company based in Montreal (Canada) founded in 2021 was acquired by GSK in February 2026. It operates as a B2B. 35Pharma offers products and services including HS135, HS235, and Ligand Traps. 35Pharma operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.

  • Headquarter Montreal, Canada
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name 35Pharma Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    GSK

    (Feb 25, 2026)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of 35Pharma

35Pharma offers a comprehensive portfolio of products and services, including HS135, HS235, and Ligand Traps. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Therapeutic for treating pulmonary hypertension and related diseases

Therapeutic for cardiometabolic disease and obesity management

Protein-based traps neutralizing pathological factors in diseases

People of 35Pharma
Headcount 10-50
Employee Profiles 13
Employee Profiles
People
Julie Bédard
Senior Director, Clinical Operations
People
Ilia A. Tikhomirov
Chief Executive Officer
People
Thomas Loisel
Vice President Of Manufacturing
People
Thomas P. Loisel
Vice President Of Manufacturing

Unlock access to complete

Funding Insights of 35Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in 35Pharma

35Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GSK. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by 35Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - 35Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

35Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of 35Pharma

35Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
R&D focused on manufacturing of drugs for multiple therapeutic areas
domain founded_year HQ Location
CDMO offering drug and biologics development services
domain founded_year HQ Location
Selective Wnt agonists are developed for human tissue regeneration.
domain founded_year HQ Location
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
domain founded_year HQ Location
Drug research, development, testing, and consulting services are provided.
domain founded_year HQ Location
Provides contract research, development, and manufacturing services for biologic drugs.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on 35Pharma

Frequently Asked Questions about 35Pharma

When was 35Pharma founded?

35Pharma was founded in 2021.

Where is 35Pharma located?

35Pharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

What does 35Pharma do?

35Pharma is a biopharmaceutical company that designs and develops biologics targeting the TGF-beta superfamily for diseases like pulmonary hypertension and obesity. It combines protein engineering expertise with rigorous manufacturing processes to create potent ligand traps. Based in Montreal, Canada, the company advances therapies through clinical trials and partnerships, aiming to improve patient outcomes with a focus on urgent medical needs.

Who are the top competitors of 35Pharma?

35Pharma's top competitors include Novartis, Surrozen and Catalent.

What products or services does 35Pharma offer?

35Pharma offers HS135, HS235, and Ligand Traps.

Who are 35Pharma's investors?

35Pharma has 1 investor. Key investors include GSK.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available